Mylan N.V. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
421
360
1,343
1,322
569
481
Total Accounts Receivable
1,820
2,269
2,689
3,311
3,612
2,881
Inventories
1,665
1,651
1,951
2,456
2,543
2,580
Other Current Assets
566
2,507
490
433
489
426
Total Current Assets
4,471
6,787
6,473
7,523
7,213
6,368
Net Property, Plant & Equipment
1,663
1,786
1,984
2,322
2,339
2,170
Total Investments and Advances
627
647
576
496
226
139
Intangible Assets
6,806
6,396
12,602
23,680
25,452
23,412
Other Assets
1,591
187
176
72
80
74
Total Assets
15,236
15,887
22,268
34,726
35,806
32,735
ST Debt & Current Portion LT Debt
440
2,736
1,000
336
1,855
Accounts Payable
1,073
906
1,110
1,348
1,453
Income Tax Payable
51
161
92
98
113
Other Current Liabilities
1,393
1,503
1,920
3,259
2,965
Total Current Liabilities
2,956
5,306
4,122
5,041
6,385
Long-Term Debt
7,586
5,733
6,296
15,203
12,865
Provision for Risks & Charges
415
450
491
308
286
Deferred Taxes
391
152
261
1,373
1,516
Other Liabilities
851
887
875
1,051
950
Total Liabilities
12,276
12,611
12,502
23,609
22,499
Common Equity (Total)
2,942
3,256
9,764
11,116
13,308
Total Shareholders' Equity
2,942
3,256
9,764
11,116
13,308
Total Equity
2,960
3,276
9,766
11,118
13,308
Liabilities & Shareholders' Equity
15,236
15,887
22,268
34,726
35,806
Accumulated Minority Interest
18
20
1
1
-

About Mylan

View Profile
Address
Building 4
Hatfield Hertfordshire AL10 9UL
United Kingdom
Employees -
Website http://mylan.co.uk
Updated 07/08/2019
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe, Rest of World, and Corporate or Other.